{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:49:28Z","timestamp":1790027368758,"version":"4.0.1"},"reference-count":43,"publisher":"Wiley","issue":"s5","license":[{"start":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T00:00:00Z","timestamp":1277164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> In this paper, the recent developments in the diagnosis and laboratory issues of von Willebrand\u2019s disease (VWD) are presented. Dr. Castaman reviews the functional tests available for the diagnosis of VWD and their pathophysiological significance, focusing on which tests are best used in the diagnosis and classification of VWD. Dr Montgomery reviews an emerging issue that is accelerated clearance of von Willebrand factor (VWF) occurring in some variants of VWD. This phenotype can be suspected by the presence of an increased ratio between the VWF propeptide and the VWF antigen. These patients have typically a robust, but short\u2010lived increase of FVIII and VWF after desmopressin. Dr Meschengieser reviews the determinants of bleeding after surgery in patients with VWD, emphasizing the role of bleeding history in predicting this risk.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2010.02296.x","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T13:51:53Z","timestamp":1277214713000},"page":"67-73","source":"Crossref","is-referenced-by-count":14,"title":["von Willebrand\u2019s disease diagnosis and laboratory issues"],"prefix":"10.1111","volume":"16","author":[{"given":"G.","family":"CASTAMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. R.","family":"MONTGOMERY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"MESCHENGIESER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"HABERICHTER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. I.","family":"WOODS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"LAZZARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,22]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-165621"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9604"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781444306286.ch8"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613765"},{"key":"e_1_2_5_6_2","first-page":"77","article-title":"A sensitive ristocetin cofactor assay with recombinat glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici AB","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1055\/s-0038-1646040","article-title":"Calibration of lyophilised standards for ristocetin cofactor activity of von Willebrand factor (VWF) requires VWF\u2010deficient plasma as a diluent for dose response curves","volume":"58","author":"Rodeghiero F","year":"1987","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613768"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1055\/s-0037-1614188","article-title":"Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease: single center comparison of four different assays","volume":"84","author":"Federici AB","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184317"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1000364"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947869"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650567"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1168"},{"key":"e_1_2_5_15_2","first-page":"388","article-title":"Effects of the mutant von Willebrand factor gene in von Willebrand disease","volume":"1995","author":"Zhang ZP","year":"1995","journal-title":"Hum Genet"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830400105"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<311::AID-AJH11>3.0.CO;2-A"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2002.00480.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03488.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015065"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03381.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(95)93844-P"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000208217"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01706.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.180"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb30984.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0037-1615235","article-title":"Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome","volume":"80","author":"Van Genderen PJ","year":"1998","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.1.179.413k18_179_185"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-110940"},{"issue":"2","key":"e_1_2_5_30_2","article-title":"Clearance of von Willebrand factor (VWF) in type 2 von Willebrand disease (VWD): the implications of VWF propeptide (VWFPP) and VWF: Ag levels","volume":"7","author":"Haberichter SL","year":"2009","journal-title":"J Thromb Haemost"},{"key":"e_1_2_5_31_2","first-page":"3225","article-title":"von Willebrand disease in the RIIIS\/J mouse is caused by a defect outside of the von Willebrand factor gene","volume":"83","author":"Nichols WC","year":"1994","journal-title":"Blood"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1182\/blood.V76.11.2258.2258","article-title":"The RIIIS\/J inbred mouse strain as a model for von Willebrand disease","volume":"76","author":"Sweeney JD","year":"1990","journal-title":"Blood"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.6.1691.1691"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-122945"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5876(99)00195-0"},{"key":"e_1_2_5_36_2","first-page":"247","article-title":"Major surgery (radical cystectomy and urethrectomy) in a patient with von Willebrand\u2019s disease type 1. Reliability and limits of hemocoagulative tests","volume":"50","author":"Favro M","year":"1998","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2003.00871.x"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01847.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0349"},{"key":"e_1_2_5_40_2","unstructured":"RodeghieroF.Bleeding Score and Bleeding Questionnaire for the Diagnosis of Type 1 von Willebrand Disease (WWW Document). Available at:http:\/\/www.med.unc.edu\/isth."},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01663.x"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.003301"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.005751"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH-07-12-0757"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2010.02296.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2010.02296.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T17:13:09Z","timestamp":1694452389000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2010.02296.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,22]]},"references-count":43,"journal-issue":{"issue":"s5","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2516.2010.02296.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02296.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,22]]}}}